Evidence map›Paper›PMID 32788409›Full record

ArticlemSystems2020

Computational Basis for On-Demand Production of Diversified Therapeutic Phage Cocktails.

Catherine M Mageeney, Anupama Sinha, Richard A Mosesso, Douglas L Medlin, Britney Y Lau, Alecia B Rokes, Todd W Lane, Steven S Branda, Kelly P Williams

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. A fully synthetic Golden Gate assembly system for engineering aProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. The TIGER/Islander resource for genomic islands.Microbiology resource announcements · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Liposomal Delivery of Newly Identified Prophage Lysins in aInternational journal of molecular sciences · 2022
    Article
  12. Review
  13. Review
  14. Exploiting interbacterial antagonism for microbiome engineering.Current opinion in biomedical engineering · 2021
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Catherine M MageeneySandia National Laboratories, Livermore, California, USA.
Anupama SinhaSandia National Laboratories, Livermore, California, USA.
Richard A MosessoSandia National Laboratories, Livermore, California, USA.
Douglas L MedlinSandia National Laboratories, Livermore, California, USA.
Britney Y LauSandia National Laboratories, Livermore, California, USA.
Alecia B RokesSandia National Laboratories, Livermore, California, USA.
Todd W LaneSandia National Laboratories, Livermore, California, USA.
Steven S BrandaSandia National Laboratories, Livermore, California, USA.
Kelly P WilliamsSandia National Laboratories, Livermore, California, USA kpwilli@sandia.gov.ORCID https://orcid.org/0000-0002-2606-9562
Sandia National Laboratories California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New therapies are necessary to combat increasingly antibiotic-resistant bacterial pathogens. We have developed a technology platform of computational, molecular biology, and microbiology tools which together enable on-demand production of phages that target virtually any given bacterial isolate. Two complementary computational tools that identify and precisely map prophages and other integrative genetic elements in bacterial genomes are used to identify prophage-laden bacteria that are close relatives of the target strain. Phage genomes are engineered to disable lysogeny, through use of long amplicon PCR and Gibson assembly. Finally, the engineered phage genomes are introduced into host bacteria for phage production. As an initial demonstration, we used this approach to produce a phage cocktail against the opportunistic pathogen

Indexed as

bioinformaticsphage therapyPseudomonas aeruginosa

Identifiers

PMID32788409
PMCPMC7426155
OpenAlexW3048968701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.